Depleting a clotting protein from the liver may help slow pancreatic cancer, according to a new study conducted by a team of researchers at the Indiana University Melvin and Bren Simon Comprehensive ...
Choosing ProPure™ proteins supports accurate experimental outcomes, enhances data reliability, and improves safety for pre-clinical animal studies, accurate cell assays, and detection assays ...
A patient in China with hepatocellular carcinoma survived 171 days following xenotransplantation with a genetically modified pig liver, the first evidence of the procedure’s feasibility in a living ...
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have found that depleting a clotting protein made by the liver could slow down pancreatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results